Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
M Petri, AM Orbai, GS Alarcón, C Gordon… - Arthritis & …, 2012 - Wiley Online Library
Abstract Objective The Systemic Lupus International Collaborating Clinics (SLICC) group
revised and validated the American College of Rheumatology (ACR) systemic lupus …
revised and validated the American College of Rheumatology (ACR) systemic lupus …
Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus a prospective analysis of 500 consecutive patients
D ALARCóN-SEGovIA, M DELEzÉ, CV ORIA… - Medicine, 1989 - journals.lww.com
In the past few years attention has been focused on the possible relationship between some
of the clinical manifestations of systemic lupus erythem-atosus (SLE) and the presence of …
of the clinical manifestations of systemic lupus erythem-atosus (SLE) and the presence of …
Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal …
MF Ugarte-Gil, A Mak, J Leong… - Lupus science & …, 2021 - lupus.bmj.com
Objective In systemic lupus erythematosus (SLE), disease activity and glucocorticoid (GC)
exposure are known to contribute to irreversible organ damage. We aimed to examine the …
exposure are known to contribute to irreversible organ damage. We aimed to examine the …
[HTML][HTML] Silicone breast implants and the risk of connective-tissue diseases and symptoms
J Sánchez-Guerrero, GA Colditz… - … England Journal of …, 1995 - Mass Medical Soc
Background Silicone breast implants have been linked to a variety of illnesses, the most
controversial of which are connective-tissue diseases and symptoms. To study this relation …
controversial of which are connective-tissue diseases and symptoms. To study this relation …
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus …
S Manzi, J Sánchez-Guerrero, JT Merrill… - Annals of the …, 2012 - ard.bmj.com
Objective To evaluate the effects of belimumab versus placebo, plus standard systemic
lupus erythematosus (SLE) therapy, on organ domain-specific SLE disease activity. Methods …
lupus erythematosus (SLE) therapy, on organ domain-specific SLE disease activity. Methods …
[HTML][HTML] A trial of contraceptive methods in women with systemic lupus erythematosus
J Sánchez-Guerrero, AG Uribe… - … England Journal of …, 2005 - Mass Medical Soc
Background The effects of estrogen-containing contraceptives on disease activity in women
with systemic lupus erythematosus have not been determined. Methods We conducted a …
with systemic lupus erythematosus have not been determined. Methods We conducted a …
Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome
G Cesarman-Maus, NP Ríos-Luna, AB Deora, B Huang… - Blood, 2006 - ashpublications.org
The association of thrombosis and gestational morbidity with antiphospholipid antibodies is
termed antiphospholipid syndrome (APS). Annexin 2 (A2) is a profibrinolytic endothelial cell …
termed antiphospholipid syndrome (APS). Annexin 2 (A2) is a profibrinolytic endothelial cell …
[HTML][HTML] Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis
H Fragoso-Loyo, J Cabiedes, A Orozco-Narváez… - PloS one, 2008 - journals.plos.org
Background Despite the uncertainty in the diagnosis of neuropsychiatric involvement in
systemic lupus erythematosus (SLE), attempts have been made to record the association of …
systemic lupus erythematosus (SLE), attempts have been made to record the association of …
How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project)
Objective. To evaluate the influence of the main immunological markers on the disease
phenotype at diagnosis in a large international cohort of patients with primary Sjogren's …
phenotype at diagnosis in a large international cohort of patients with primary Sjogren's …
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort …
S Retamozo, N Acar-Denizli… - Clinical and …, 2019 - discovery.ucl.ac.uk
OBJECTIVES: To analyse the frequency and characterise the systemic presentation of
primary Sjögren's syndrome (SS) out of the ESSDAI classification in a large international …
primary Sjögren's syndrome (SS) out of the ESSDAI classification in a large international …